Brief: Revelation Biosciences Announces Future Clinical Development Plans Based On Recent Biomarker Analysis And Significant Reduction In New Collagen Deposition (Fibrosis) In Preclinical Model
18/11/2022 14:09
Nov 18 (Reuters) - Revelation Biosciences Inc REVB.O :
* REVELATION BIOSCIENCES INC. ANNOUNCES FUTURE CLINICAL
DEVELOPMENT PLANS BASED ON RECENT BIOMARKER ANALYSIS AND
SIGNIFICANT REDUCTION IN NEW COLLAGEN DEPOSITION (FIBROSIS) IN
PRECLINICAL MODEL
Source text for Eikon: ID:nBw3Hn2XWa
Further company coverage: REVB.O